Role of betacellulin in diabetic macular edema
Role of betacellulin in diabetic macular edema
批准号:
8657047
负责人:
BELA ANAND-APTE
金额:
$38.47万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2016-03-31
关键词:
BindingBlindnessBlood VesselsBlood-Retinal BarrierCardiovascular DiseasesCellsCleaved cellComplications of Diabetes MellitusDevelopmentDiabetes MellitusDiabetic RetinopathyDiabetic mouseDisintegrinsEpidemicEpidemiologic StudiesEpidermal Growth FactorExtravasationExudateFamilyFutureHumanHyperglycemiaHyperglycemic MiceHypoglycemiaIncidenceInsulinIntervention StudiesIslet CellLeadLiquid substanceMaintenanceMembraneMetalloproteasesModalityMolecularMorbidity - disease rateNatural regenerationNon-Insulin-Dependent Diabetes MellitusPancreasPathogenesisPathologyPatientsPermeabilityPhysiologicalPlasmaPlayProliferatingReportingRetinaRetinalRetinal DiseasesRetinal HemorrhageRiskRoleSmooth Muscle MyocytesStructure of retinal pigment epitheliumTestingTight JunctionsVascular PermeabilitiesVisionbasebetacellulindiabeticdisorder of macula of retinaglycemic controlhigh riskintravitreal injectionmaculamacular edemamembermortalitypreventproliferative diabetic retinopathypublic health relevanceretina blood vessel structuresolutetherapeutic development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The incidence of diabetes world-wide, is expected to reach epidemic proportions by 2025. Progression of diabetic retinopathy often results in diabetic macular edema, which is a consequence of the breakdown of the blood-retinal barrier, increased retinal vascular permeability and leakage of plasma from small blood vessels in the macula leading to loss of central vision. The degree of hyperglycemia and duration of diabetes have been shown to be good predictors of retinal complications. Intervention studies have determined that while intensive treatment of diabetes reduced the development of proliferative diabetic retinopathy it was associated with an increased risk of mortality from cardiovascular disease (Ismail-Beigi June 29, 2010 Lancet online) as well as with a higher morbidity risk from hypoglycemic episodes. We reason that it is critical to identify a downstream glycemic target that causes increased retinal vascular permeability that could be targeted therapeutically without the additional risks associated with intensive treatment of the hyperglycemia. Betacellulin is a 32 kD member of the epidermal growth factor family that is produced by proliferating ¿ cells of the islets and promotes regeneration of pancreatic ¿ cells. We hypothesize a role for betacellulin in the retinal vascular complications associated with diabetes based on our preliminary studies, which show that diabetic mice have accentuated retinal vascular permeability with a concomitant increased expression of a cleaved soluble form of betacellulin (s-Btc) in the retina. Intravitreal injection of betacellulin induced retinal hemorrhage and increased vascular permeability in normoglycemic and hyperglycemic mice. A disintegrin and metalloproteinase, ADAM-10 (which plays a role in the cleavage of betacellulin), is increased in the retinae of diabetic mice and humans with diabetic retinopathy. Based on these preliminary results we hypothesize that betacellulin contributes to increased retinal vascular permeability and the pathogenesis of diabetic macular edema.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Regulation of retinal vascular permeability by betacellulin.
β细胞素调节视网膜血管通透性。
DOI:
10.1007/978-1-4614-0631-0_38
发表时间:
2012
期刊:
Advances in experimental medicine and biology
影响因子:
--
作者:
[Sugimoto,Masahiko, Cutler,Alecia, Grossman,Gregory, Anand-Apte,Bela]
通讯作者:
Anand-Apte,Bela
Regulation of Choroidal Neovascularization in Sorsby's Fundus Dystrophy
-
批准号:9900004
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2017
-
负责人:BELA ANAND-APTE
-
依托单位:
FGF and hyaluronan-mediated alterations in epithelial-mesenchymal transition and metabolism of RPE cells in Sorsby Fundus Dystrophy.
-
批准号:10408757
-
项目类别:
-
资助金额:$62.17万
-
财政年份:2017
-
负责人:BELA ANAND-APTE
-
依托单位:
FGF and hyaluronan-mediated alterations in epithelial-mesenchymal transition and metabolism of RPE cells in Sorsby Fundus Dystrophy.
-
批准号:10636830
-
项目类别:
-
资助金额:$61.01万
-
财政年份:2017
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.
-
批准号:9769753
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
NEI CENTER CORE GRANT FOR VISION RESEARCH
-
批准号:9336307
-
项目类别:
-
资助金额:$63.4万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
NEI Center Core Grant for Vision Research
-
批准号:10273076
-
项目类别:
-
资助金额:$64.4万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
CORE A - Administrative Core
-
批准号:10273077
-
项目类别:
-
资助金额:$2.26万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
NEI Center Core Grant for Vision Research
-
批准号:10670892
-
项目类别:
-
资助金额:$64.4万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.
-
批准号:9334214
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.
-
批准号:10011815
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
Cole Eye Institute Vision Science Training Program
-
批准号:10407662
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2015
-
负责人:BELA ANAND-APTE
-
依托单位:
Cole Eye Institute Vision Science Training Program
-
批准号:10595051
-
项目类别:
-
资助金额:$3.62万
-
财政年份:2015
-
负责人:BELA ANAND-APTE
-
依托单位:
Cole Eye Institute Vision Science Training Program
-
批准号:9027846
-
项目类别:
-
资助金额:$17.4万
-
财政年份:2015
-
负责人:BELA ANAND-APTE
-
依托单位:
Cole Eye Institute Vision Science Training Program
-
批准号:9262929
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2015
-
负责人:BELA ANAND-APTE
-
依托单位:
Cole Eye Institute Vision Science Training Program
-
批准号:8855069
-
项目类别:
-
资助金额:$16.87万
-
财政年份:2015
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of betacellulin in diabetic macular edema
-
批准号:8231532
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of betacellulin in diabetic macular edema
-
批准号:8107705
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of betacellulin in diabetic macular edema
-
批准号:8449210
-
项目类别:
-
资助金额:$37.29万
-
财政年份:2011
-
负责人:BELA ANAND-APTE
-
依托单位:
CAN CD 133 CELLS PREVENT HYPOXIA DRIVEN RETINAL NEOVASCULARISATION IN A RODENT MO
-
批准号:7405687
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2007
-
负责人:BELA ANAND-APTE
-
依托单位:
Inhibition of VEGF Mediated Angiogenesis by TIMP-3
-
批准号:7112292
-
项目类别:
-
资助金额:$26.82万
-
财政年份:2005
-
负责人:BELA ANAND-APTE
-
依托单位:
海外基金